Communications Biology (Jul 2021)

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

  • Teresa Lambe,
  • Alexandra J. Spencer,
  • Kelly M. Thomas,
  • Karen E. Gooch,
  • Stephen Thomas,
  • Andrew D. White,
  • Holly E. Humphries,
  • Daniel Wright,
  • Sandra Belij-Rammerstorfer,
  • Nazia Thakur,
  • Carina Conceicao,
  • Robert Watson,
  • Leonie Alden,
  • Lauren Allen,
  • Marilyn Aram,
  • Kevin R. Bewley,
  • Emily Brunt,
  • Phillip Brown,
  • Breeze E. Cavell,
  • Rebecca Cobb,
  • Susan A. Fotheringham,
  • Ciaran Gilbride,
  • Debbie J. Harris,
  • Catherine M. K. Ho,
  • Laura Hunter,
  • Chelsea L. Kennard,
  • Stephanie Leung,
  • Vanessa Lucas,
  • Didier Ngabo,
  • Kathryn A. Ryan,
  • Hannah Sharpe,
  • Charlotte Sarfas,
  • Laura Sibley,
  • Gillian S. Slack,
  • Marta Ulaszewska,
  • Nadina Wand,
  • Nathan R. Wiblin,
  • Fergus V. Gleeson,
  • Dalan Bailey,
  • Sally Sharpe,
  • Sue Charlton,
  • Francisco J. Salguero,
  • Miles W. Carroll,
  • Sarah C. Gilbert

DOI
https://doi.org/10.1038/s42003-021-02443-0
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 12

Abstract

Read online

Lambe, Spencer, Thomas, Gilbert and colleagues report on the detailed immune profile of rhesus macaques and ferrets vaccinated against SARS-CoV-2 under high dose challenge. Their findings indicate that the ChAdOx1 nCoV-19 (AZD1222) the vaccine induces immune responses and reduces disease symptoms in both models, including SARS-CoV-2 mediated pneumonia and virus shedding.